OpGen (NASDAQ:OPGN) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Trading Up 0.7 % Shares of OPGN opened at $1.38 on Thursday. OpGen has a fifty-two week low of $0.53 and a fifty-two week high […]
